Navigation Links
Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2008
Date:4/21/2008

e $0.71 $0.54

2)Results for the first quarter of 2007 include pre-tax charges of

$10.7 million associated with workforce reductions in response to

reduced volume levels. Of these costs, $3.9 million and $6.8 million,

respectively, were included in cost of services and selling, general and

administrative expenses.

3)Other operating expense, net represents miscellaneous income and expense

items related to operating activities including gains and losses

associated with the disposal of operating assets and provisions for

restructurings and other special charges. For the three months ended

March 31, 2007, other operating expense, net includes a $4.0 million

charge related to in-process research and development expense associated

with HemoCue, which the Company acquired on January 31, 2007.

4)The following table summarizes the approximate impact of various items

on year-over-year comparisons for certain revenue metrics reported for

the quarter ended March 31, 2008, and is included for informational

purposes only:

Continuing Operations

Three Months Ended

March 31, 2008

Consolidated Volume Revenue

Revenue Growth Growth per Requisition

Growth

Reported: 16.9% 5.6% 10.8%

Impact on comparisons to

prior year of:

Impact of contract change (0.8)% (1.6)% 0.4%

Acquisitions:

AmeriPath 13.0% 5.8% 7.8%

Other 0.5%
'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Vioxx Disclosure Emphasizes Need for New Web Resource that Answers Questions About Anti-Epileptic Medication Use
2. Susan G. Komen for the Cure Advocacy Alliance Suggests Questions for Tonights Presidential Debate
3. ImQuest Presents New Anti-HIV Drug and Topical Microbicide Development Results on Lead Pyrimidinedione Products IQP-0410 and IQP-0528
4. Quest Diagnostics to Release First Quarter 2008 Financial Results and Conduct Quarterly Investor Conference Call
5. New conference tackles the tough questions in lung cancer
6. The Quest for Americas Life in Beautiful Smiles: Captured in Photography
7. SurgiQuest Announces First Procedure Using AirSeal(TM) Access System
8. Study questions cost of complexity in evolution
9. Conseco Declines Partnerships Request for Board Seats; Review of Strategic Alternatives Underway
10. Large Disparities in Kidney Testing Based on Disease, Gender and State, Quest Diagnostics Health Trends(TM) Report Finds
11. Use of Methamphetamine Among U.S. Workers and Job Applicants Drops 22 Percent in 2007 and Cocaine Use Slows Dramatically, Reports Quest Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 2ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 3Ascension Orthopedics Hires Key Senior Executives 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 3BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 4Caltech researchers explore how cells reconcile mixed messages in decisions about growth 8919 1Caltech researchers explore how cells reconcile mixed messages in decisions about growth 8919 2Caltech researchers explore how cells reconcile mixed messages in decisions about growth 8919 3More Than 5 000 Expected for Greater Chicago Food Depositorys 24th Annual Hunger Walk on Saturday June 20 at Montrose Harbor 49468 1More Than 5 000 Expected for Greater Chicago Food Depositorys 24th Annual Hunger Walk on Saturday June 20 at Montrose Harbor 49468 2After Major Ruling on Unsafe Lead Levels in Paint Experts Reveal How You Can Ensure Your Kids Are Safe 49465 1After Major Ruling on Unsafe Lead Levels in Paint Experts Reveal How You Can Ensure Your Kids Are Safe 49465 2